SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-234877
Filing Date
2012-05-15
Accepted
2012-05-15 16:56:06
Documents
16
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d354472d10q.htm 10-Q 353023
2 EX-10.1 d354472dex101.htm EX-10.1 43907
3 EX-10.3 d354472dex103.htm EX-10.3 8918
4 EX-10.5 d354472dex105.htm EX-10.5 9040
5 EX-10.7 d354472dex107.htm EX-10.7 8846
6 EX-10.8 d354472dex108.htm EX-10.8 35873
7 EX-10.9 d354472dex109.htm EX-10.9 36711
8 EX-10.10 d354472dex1010.htm EX-10.10 35985
9 EX-31.1 d354472dex311.htm EX-31.1 10739
10 EX-32.1 d354472dex321.htm EX-32.1 5605
16 GRAPHIC g354472g64q45.jpg GRAPHIC 10507
  Complete submission text file 0001193125-12-234877.txt   1265974

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT rgn-20120331.xml EX-101.INS 60811
12 XBRL TAXONOMY EXTENSION SCHEMA rgn-20120331.xsd EX-101.SCH 7584
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgn-20120331_cal.xml EX-101.CAL 19753
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgn-20120331_lab.xml EX-101.LAB 76273
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgn-20120331_pre.xml EX-101.PRE 47895
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 12845669
SIC: 2834 Pharmaceutical Preparations